Susanna Ling

Vice President, Industry Programs and Partnerships
​Biotechnology Innovation Organization (BIO)
 

Susanna is a progressive and results-oriented executive with strategic development, relationship management, revenue generation, and programming experience gained from working with biotechnology, pharmaceutical, and non-profit organizations ranging from start-ups to Fortune 100 companies. 
With over 25 years of industry experience, starting as a researcher at NIH and working on commercialization projects at MedImmune and Guilford Pharma before working at international organizations such as the Milken Institute, EBD Group/Informa, and BIO, Susanna is an innovative leader in the development and implementation of international biopharma programs.
Susanna works closely with C-suite executives, BD professionals, patient advocates, KOL’s, investors, and other industry stakeholders. She is an advocate for diversity and equity, and leads change management programs that foster greater access, inclusion, and opportunities for underrepresented communities. 
In her current role at BIO, she leads cross-functional teams to build relationships and partnerships that facilitate the advancement of R&D, BD, and commercialization objectives to ultimately benefit patients.